English, PDF, 126kb
The quality of health care is generally very good in Japan but further improvement can be made in the management of diabetes, treatment of heart attack (AMI), and cancer control. In Japan, per capita spending on pharmaceuticals is the second highest in the OECD after the United States. Spending on pharmaceuticals could be reduced by increasing the share of the generic market.
Base de données Statistiques de l'OCDE sur la santé 2015 - Notes par pays
A dashboard of key government indicators by country, to help you analyse international comparisons of public sector performance.
English, PDF, 424kb
English, PDF, 310kb
Japan has been successful at reducing the mortality due to cardiovascular diseases (CVD) but there is room to reduce the burden of CVD and diabetes even more.
English, PDF, 355kb
To achieve greater gender equality in employment and more inclusive growth, Japan needs to change the workplace culture and ensure that the tax and social security systems do not reduce work incentives for second earners in households.
English, PDF, 397kb
The Japanese economy has for many years been characterised by a low corporate return on equity. Increasing returns requires better corporate governance that improves investment and the use of corporate resources, including cash holdings.
English, PDF, 409kb
Japan has the potential to grow its agricultural sector, including by producing high-value products that reflect the country’s growing reputation for sophisticated, healthy, and high-quality food. To assure the long-term health of Japan’s food and agriculture system, it is critical to increase its capacity to respond to market demands.
English, PDF, 1,077kb
This country note provides information on latest trends in income inequalities as well as key findings from the 2015 OECD report "In it Together: Why less inequality benefits all".